Government ContextGovernment Context
TopicsAgenciesOrganizationsDocumentsPricingLog inCreate account
TopicsAgenciesOrganizationsDocumentsPricing
LoginCreate account
Organizations › Critical Path Institute
CP

Critical Path Institute

Advocacy/org/critical-path-institute
Comments
4
Dockets
3
Support
3
Oppose
0

Activity

No recent organization activity yet. Historical comments remain available in the record.

Comment record

Recent public comments attributed to this organization.

  • FDA-2026-N-2476-0038
    Jun 5
  • General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
    May 20Support
  • Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause; Draft Guidance for Industry
    Apr 30Support
  • Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products Guidance for Industry and Other Interested Parties; Draft Guidance
    Apr 8Support
Government ContextGovernment Context

Track federal rulemaking documents, topics, and agencies — built on primary sources across the federal government.

ExploreDocumentsTopicsAgenciesOrganizations
CompanyAboutData sourcesPricing
LegalPrivacyTerms
© 2026 Government Context. Built on primary government sources.Not affiliated with any U.S. government agency.